echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Emerg Microbes Infect: A multicenter cross-sectional study on the prevalence and risk factors of active pulmonary tuberculosis in patients with rheumatic disease

    Emerg Microbes Infect: A multicenter cross-sectional study on the prevalence and risk factors of active pulmonary tuberculosis in patients with rheumatic disease

    • Last Update: 2022-02-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Patients with rheumatic diseases are at high risk of developing ATB due to the underlying disease and the use of immunosuppressive



    screening



    Patients with rheumatic diseases have a higher prevalence of ATB compared to the general population


    Liu X, Zhang L, Zhang F,Prevalence and Risk Factors of Active Tuberculosis in Patients with Rheumatic Diseases: A Multi-center, Cross-Sectional Study in China.


    Liu X, Zhang L, Zhang F,Prevalence and Risk Factors of Active Tuberculosis in Patients with Rheumatic Diseases: A Multi-center, Cross-Sectional Study in China.
    Emerg Microbes Infect 2021 Nov 10;

    Leave a Comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.